Leprosy: a review of epidemiology, clinical diagnosis, and management
KH Chen, CY Lin, SB Su… - Journal of Tropical …, 2022 - Wiley Online Library
Leprosy is a neglected infectious disease caused by acid‐fast bacillus Mycobacterium
leprae. It primarily affects the skin and then progresses to a secondary stage, causing …
leprae. It primarily affects the skin and then progresses to a secondary stage, causing …
Pathogenicity and virulence of Mycobacterium leprae
M Sugawara-Mikami, K Tanigawa, A Kawashima… - Virulence, 2022 - Taylor & Francis
Leprosy is caused by Mycobacterium leprae (M. leprae) and M. lepromatosis, an obligate
intracellular organism, and over 200,000 new cases occur every year. M. leprae parasitizes …
intracellular organism, and over 200,000 new cases occur every year. M. leprae parasitizes …
Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study
WS da Paz, M do Rosario Souza… - The Lancet Regional …, 2022 - thelancet.com
Background The pandemic caused by COVID-19 has seriously affected global health,
resulting in the suspension of many regular health services, making the diagnosis of other …
resulting in the suspension of many regular health services, making the diagnosis of other …
Leprosy: clinical aspects and diagnostic techniques
MBC Maymone, M Laughter, S Venkatesh… - Journal of the American …, 2020 - Elsevier
Leprosy, also known as Hansen's disease, is a curable infectious disease that remains
endemic in> 140 countries around the world. Despite being declared “eliminated” as a …
endemic in> 140 countries around the world. Despite being declared “eliminated” as a …
Risk factors for physical disability in patients with leprosy: a systematic review and meta-analysis
HL de Paula, CDF de Souza, SR Silva… - JAMA …, 2019 - jamanetwork.com
Importance The World Health Organization (WHO) 2016-2020 Global Leprosy Strategy aims
to reinvigorate efforts to control leprosy and avert leprosy disability to less than 1 per million …
to reinvigorate efforts to control leprosy and avert leprosy disability to less than 1 per million …
Leprosy: A great imitator
N Kundakci, C Erdem - Clinics in dermatology, 2019 - Elsevier
In recent years, advances in medical diagnosis and treatment have greatly attracted our
attention, whereas some rare diseases, such as leprosy, have not found a place in the …
attention, whereas some rare diseases, such as leprosy, have not found a place in the …
Neuropathies of leprosy
SV Khadilkar, SB Patil, VP Shetty - Journal of the neurological sciences, 2021 - Elsevier
Neuropathies form an integral part of the symptomatology of leprosy. Neuropathies of
leprosy take various forms and shapes. At one end is the cutaneous nerve involvement …
leprosy take various forms and shapes. At one end is the cutaneous nerve involvement …
Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases
W DeGroat, H Abdelhalim, E Peker, N Sheth… - Scientific Reports, 2024 - nature.com
Cardiovascular diseases (CVDs) are complex, multifactorial conditions that require
personalized assessment and treatment. Advancements in multi-omics technologies …
personalized assessment and treatment. Advancements in multi-omics technologies …
[HTML][HTML] Leprosy in Brazil: an analysis of the Global Burden of Disease estimates between 1990 and 2019
VEM de Araújo, GA Veloso, L Kerr, JM Pescarini… - Public health, 2024 - Elsevier
Objective To analyze the occurrence of leprosy in Brazil and its states between 1990 and
2019, according to Global Burden of Disease (GBD) estimates, and its correlation with …
2019, according to Global Burden of Disease (GBD) estimates, and its correlation with …
The interplay between neuroinfections, the immune system and neurological disorders: a focus on Africa
Neurological disorders related to neuroinfections are highly prevalent in Sub-Saharan Africa
(SSA), constituting a major cause of disability and economic burden for patients and society …
(SSA), constituting a major cause of disability and economic burden for patients and society …